Predictive performance of single-trough Bayesian estimation for vancomycin across body mass index categories using Practical Antimicrobial Therapeutic Drug Monitoring (PAT) version 4.0
Predictive performance of single-trough Bayesian estimation for vancomycin across body mass index categories using Practical Antimicrobial Therapeutic Drug Monitoring (PAT) version 4.0. // Journal of Infection and Chemotherapy. – URL: https://www.sciencedirect.com/science/article/pii/S1341321X2600187X?dgcid=rss_sd_all
Predictive performance of single-trough Bayesian estimation for vancomycin across body mass index categories using Practical Antimicrobial Therapeutic Drug Monitoring (PAT) version 4.0. Journal of Infection and Chemotherapy. https://www.sciencedirect.com/science/article/pii/S1341321X2600187X?dgcid=rss_sd_all
“Predictive performance of single-trough Bayesian estimation for vancomycin across body mass index categories using Practical Antimicrobial Therapeutic Drug Monitoring (PAT) version 4.0.” Journal of Infection and Chemotherapy.
@article{article107944,
title = {Predictive performance of single-trough Bayesian estimation for vancomycin across body mass index categories using Practical Antimicrobial Therapeutic Drug Monitoring (PAT) version 4.0},
journal = {Journal of Infection and Chemotherapy},
url = {https://www.sciencedirect.com/science/article/pii/S1341321X2600187X?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...